Effect of Polyvinylpyrrolidone on Complexation and Dissolution Rate of Beta Cyclodextrin and Hydroxypropyl Beta Cyclodextrin Complexes of Piroxicam

被引:0
|
作者
Kumar, Otra [1 ]
Rani, A. Prameela [2 ]
机构
[1] Drugs Control Adm, Eluru, West Godavari, India
[2] Acharya Nagarjuna Univ, Univ Coll Pharmaceut Sci, Guntur, India
关键词
Piroxicam; Cyclodextrin; Dissolution; Polyvinylpyrrolidone; Complexation;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Complexation of Piroxicam with beta-Cyclodextrin and hydroxypropyl-beta-Cyclodextrin in the presence and absence of polyvinylpyrrolidone and the effect of polyvinylpyrrrolidone on the solubilizing efficiency of Cyclodextrins and on the dissolution rate of Piroxicam from the Cyclodextrin complexes were investigated. The phase solubility studies indicated the formation of Piroxicam-beta-Cyclodextrin and Piroxicam-hydroxypropyl-beta Cyclodextrin inclusion complexes at a 1:1 M ratio in solution, both in the presence and absence of polyvinylpyrrolidone. The complexes formed were quite stable. The solubility and dissolution rate of Piroxicam were markedly enhanced by complexation with beta-Cyclodextrin and hydroxypropyl- beta-Cyclodextrin. Piroxicamhydroxypropyl- beta-Cyclodextrin(1:2) inclusion complex gave a 36.52- fold increase in the dissolution rate of Piroxicam. Addition of polyvinylpyrrolidone resulted in higher complexation efficiency and markedly enhanced solubilizing efficiency of beta-Cyclodextrin and hydroxypropyl-beta-Cyclodextrin. Solid inclusion complexes of Cyclodextrins with polyvinylpyrrolidone gave several times higher rates of dissolution than those of Piroxicam and its complexes with Cyclodextrins alone.
引用
收藏
页码:301 / 305
页数:5
相关论文
共 50 条
  • [41] Dissociation constants of host-guest complexes of alkyl-bearing compounds with beta-cyclodextrin and ''hydroxypropyl-beta cyclodextrin''
    Tee, OS
    Gadosy, TA
    Giorgi, JB
    [J]. CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1996, 74 (05): : 736 - 744
  • [42] IMPROVEMENT OF DISSOLUTION AND ABSORPTION CHARACTERISTICS OF UBIDECARENONE BY DIMETHYL-BETA-CYCLODEXTRIN COMPLEXATION
    UENO, M
    IJITSU, T
    HORIUCHI, Y
    HIRAYAMA, F
    UEKAMA, K
    [J]. ACTA PHARMACEUTICA NORDICA, 1989, 1 (02): : 99 - 104
  • [43] PERMEATION OF PIROXICAM AND PIROXICAM-BETA-CYCLODEXTRIN THROUGH ARTIFICIAL MEMBRANES
    BETTINI, R
    SANTI, P
    CATELLANI, PL
    MASSIMO, G
    BELLOTTI, A
    BARTHELEMY, C
    GUYOTHERMANN, AM
    TRUBLIN, F
    COLOMBO, P
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1992, 38 (06) : 203 - 208
  • [44] SUPPORT FOR THE PROPOSED OBSERVATION BY IONSPRAY MASS-SPECTROMETRY OF PIROXICAM/BETA-CYCLODEXTRIN AND TERFENADINE/BETA-CYCLODEXTRIN NONCOVALENT INCLUSION COMPLEXES
    SELVA, A
    REDENTI, E
    ZANOL, M
    VENTURA, P
    CASETTA, B
    [J]. EUROPEAN MASS SPECTROMETRY, 1995, 1 (01): : 105 - 106
  • [45] Effect of β-cyclodextrin and hydroxypropyl β-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir
    Aleem, Omair
    Kuchekar, Bhanudas
    Pore, Yogesh
    Late, Sameer
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 47 (03) : 535 - 540
  • [46] EFFECT OF HYDROTROPIC SUBSTANCES ON THE COMPLEXATION OF CLOTRIMAZOLE WITH BETA-CYCLODEXTRIN
    PEDERSEN, M
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (04) : 439 - 448
  • [48] Characterization and in vitro dissolution behaviour of ketoconazole/beta- and 2-hydroxypropyl-beta-cyclodextrin inclusion compounds
    EsclusaDiaz, MT
    GuimaraensMendez, M
    PerezMarcos, MB
    VilaJato, JL
    TorresLabandeira, JJ
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 143 (02) : 203 - 210
  • [49] Enhancement of apixaban's solubility and dissolution rate by inclusion complex (β-cyclodextrin and hydroxypropyl β-cyclodextrin) and computational calculation of their inclusion complexes
    Salman, Zainab N.
    Al-Ani, Israa
    Al Azzam, Khaldun M.
    Majeed, Bashar J. M.
    Abdallah, Hassan H.
    Negim, El-Sayed
    [J]. ADMET AND DMPK, 2023, 11 (04): : 533 - 550
  • [50] Evaluation of Solubility, Dissolution Rate, and Oral Bioavailability of β-Cyclodextrin and Hydroxypropyl β-Cyclodextrin as Inclusion Complexes of the Tyrosine Kinase Inhibitor, Alectinib
    Majeed, Bashar J. M.
    Saadallah, Mohammed A.
    Al-Ani, Israa H.
    El-Tanani, Mohamed K.
    Al Azzam, Khaldun M.
    Abdallah, Hassan H.
    Al-Hajji, Feras
    [J]. PHARMACEUTICALS, 2024, 17 (06)